Communiqués PTC Therapeutics, Inc.

Actions

PTCT

US69366J2006

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
36,36 ^USD	+1,54 %		-2,26 %	+31,93 %

24/05	Un initié de Ptc Therapeutics a vendu des actions pour une valeur de 764 800 $, selon un récent dépôt auprès de la SEC	MT
21/05	PTC THERAPEUTICS, INC. : Goldman Sachs toujours négatif	ZM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PTC Therapeutics to Participate at Upcoming Investor Conference	29/05	PR
PTC Therapeutics Announces Validation of Sepiapterin European MAA	28/05	PR
PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation	20/05	PR
PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™	14/05	PR
PTC Therapeutics : Corporate Presentation – May 2024	04/05	PU
PTC Therapeutics to Participate at Upcoming Investor Conferences	02/05	PR
PTC Therapeutics : Q1 2024 FLS	25/04	PU
PTC Therapeutics: Q1 Earnings Snapshot	25/04	AQ
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results	25/04	PR
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	24/04	AQ
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23/04	PR
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results	12/04	AQ
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results	11/04	PR
PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA	28/03	PR
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza as a Treatment for AADC Deficiency	20/03	AQ
PTC Therapeutics Provides Key Regulatory Updates	19/03	PR
PTC Therapeutics: Q4 Earnings Snapshot	29/02	AQ
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results	29/02	PR
PTC Therapeutics to Participate at Upcoming Investor Conferences	27/02	PR
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	22/02	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués PTC Therapeutics, Inc.

Actions

PTCT

US69366J2006

Communiqués

Filtres